Quantum Coast Capital Founder Matt Cimaglia Discusses 2 Billion Grant for Quantum Industry Illinois Payrolls Rise in March Unemployment Rate Edges Higher UnitedHealth Group Gains Hedge Fund Interest as Dividend Stock with Mizuho Price Target Hike Solstice Surpasses 400M Total Value Locked as NYSEListed Bullish Becomes Institutional Allocator Wall Street Analyst Sentiment on Illinois Tool Works A Closer Look T Rowe Price Group High Yield Retirement Income Stock Reports AUM Growth and Net Outflows United Rentals URI Q1 2026 Earnings Solid EPS Beat Powered by Operational Strength NTCT Q1 2026 Earnings EPS Surpasses Estimates as Company Delivers Strong Profitability BHB Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Credit Environment STTK Q1 2026 Earnings Shattuck Labs Reports Narrower Loss Beats EPS Estimates SEER Q1 2026 Earnings Narrowly Beats EPS Estimates as Company Maintains Cost Discipline Eagle Financial Services Inc EFSI Pulls Back From Resistance Testing NearTerm Support RingCentral RNG Rallies 3 as Shares Test Key Technical Resistance Marchex MCHX Edges Higher as Stock Holds Above Key Support Level MPLX Declines 135 Assessing Support and Resistance Levels Westlake Chemical Partners WLKP Edges Higher Amid Steady Volume and Stable Support Levels Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Ares Commercial Real Estate Corporation ACRE Q1 2026 Earnings Deep Loss Surprises Market as Net Interest Income Weighs Ambow Education AMBO Bounces Back Stock Rises 38 as Price Approaches Resistance Quest Resource Holding QRHC Edges Higher Near Key Support Level at 109 Oak Woods Acquisition Warrants OAKUW Gain 311 to 002 A Tight Range at RockBottom Levels SMJ International Holdings SMJF Rallies 234 as Stock Approaches Resistance at 505 Abundia Global Impact Group AGIG Surges 446 Testing Resistance at 123 EyePoint Inc EYPT Gains 486 as Stock Tests Resistance at 1449 EHang Holdings EH Rallies 770 Support and Resistance Levels in Focus Amylyx Pharmaceuticals AMLX Gains 344 as Biotech Sentiment Lifts Shares